This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
22nd Century Group, Inc., a plant biotechnology company, focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding.View XXII key stats
22nd Century Group Inc. - XXII - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates 22nd Century Group Inc. as a
Sell with a ratings score of D.
Report Snippet: We rate 22ND CENTURY GROUP INC (XXII) a SELL. This is driven by a number of negative factors, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow and generally disappointing historical performance in the stock itself.